[PDF] Top 20 Insight Into Parkinson's Disease Using Yeast as a Model to Evaluate the Role of Autophagy Genes in alpha-Synuclein Toxicity
Has 10000 "Insight Into Parkinson's Disease Using Yeast as a Model to Evaluate the Role of Autophagy Genes in alpha-Synuclein Toxicity" found on our website. Below are the top 20 most common "Insight Into Parkinson's Disease Using Yeast as a Model to Evaluate the Role of Autophagy Genes in alpha-Synuclein Toxicity".
Insight Into Parkinson's Disease Using Yeast as a Model to Evaluate the Role of Autophagy Genes in alpha-Synuclein Toxicity
... prion disease, Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington disease (HD), and Multiple Sclerosis ...the disease causing agent is transmitted between ... See full document
18
Alpha-Synuclein Aggregation and Membrane Association in a Fission Yeast Model: Implications for PD Pathogenesis
... Parkinson’s disease (PD) ...developed model organism of fission ...α synuclein expression studied was either high or low, the wild-type and A53T familial mutant of α α- α α synuclein followed ... See full document
8
Genetic Evidence in Yeast Model Implicates Autophagy in the Degradation of Parkinson's Disease Protein alpha-Synuclein
... a role in regulating neurotransmitter vesicle pools (Jensen et ...α- synuclein leading to PD include misfolding (Winreb et ...α- Synuclein shows a gain in toxic function and expresses PD symptoms and ... See full document
10
The Role of Alpha- Synuclein And Other Parkinson’s Genes in Neurodevelopmental and Neurodegenerative Disorders
... mouse model encompassing the 22q11 genomic deletion region, the Df1/+ model [108], was found to have elevated levels of α-syn and p62, a key receptor for ...causative genes in this large deletion ... See full document
30
Clinicogenetics of Parkinson’s disease: a drawing but not completed picture
... at disease risk, disease progression, or ...the disease and to predict the risk for developing the ...a disease usually display a high penetrance (> 80%), and the variability of AAOs of ... See full document
12
The role of alpha-synuclein and other
... Figure S1: A. UCSC genome browser custom tracks (genome build GRCh37/hg19, February 2009) for two SNCA triplication cases (red) and one SNCA duplication (blue). B. Illustration of comparative genomic hybridization (CGH) ... See full document
15
Alpha synuclein truncation and disease
... of alpha-synuclein has not been clearly established, observations related to the protein’s cellular localization have provided clues to its ...a role for al- pha-synuclein have relied on ... See full document
11
Expression and Characterization Studies of a-Synuclein to Model Parkinson's Disease in Yeast
... Parkinson’s disease (PD) is a fatal, incurable, neurodegenerative disease that affects approximately 4 million people ...this disease, dopaminergic neurons selectively die causing symptoms of ... See full document
18
Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity
... AS toxicity are mediated by changes in mitochondrial function, since AS in- hibits mitochondrial respiration and complex I activity [8, ...analysis using the fluorescent Mito- tracker reagent (Additional ... See full document
17
Springer, Wolfdieter (2005): Caenorhabditis elegans as an Experimental Model Organism to Study Parkinson's Disease-Related Genes: Functional Analysis of Parkin and alpha-Synuclein. Dissertation, LMU München: Fakultät für Chemie und Pharmazie
... of genes, as well as determination of the subcellular localization of their products, as it can easily be transformed with reporter constructs, ...predicted genes of which 43% have human homologs, including ... See full document
183
Alpha-Synuclein Toxicity is Caused by Mitochondrial Dysfunction
... that yeast cells that use oxidative phosphorylation for energy production show increased aSyn toxicity and aggregation (Figure 9, ...increased toxicity and aggregation is not caused merely by higher ... See full document
130
O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson’s disease
... Parkinson’s disease, since α-synuclein accumulation has been shown in neurons and neurites in Parkinson’ s disease postmortem brains and we found an elevation of O-GlcNAcylated proteins ... See full document
14
Toxicity of levodopa in parkinson disease therapy
... parkinson's disease: PD is a chronic progressive degenerative disease of the Central Nervous System (CNS) that affects a region of the brain known as the "Extrapyramidal System", formed by the ... See full document
6
Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy
... in autophagy regulation are the MEK/ERK and the PI3K/AKT/mTOR signaling pathways [33], which are commonly deregulated in CRC [36, ...regulate autophagy in CRC. Here, we demonstrate that KRAS- induced ... See full document
16
The role of rasagiline in the treatment of Parkinson’s disease
... A total of 404 subjects with early PD were randomized to receive placebo, rasagiline 1 mg/day, or rasagiline 2 mg/day. Subjects had to be over age 35 with at least 2 cardinal signs of PD and disease severity of ... See full document
8
Study protocol of “CHAPS”: a randomized controlled trial protocol of Care Coordination for Health Promotion and Activities in Parkinson’s Disease to improve the quality of care for individuals with Parkinson’s disease
... the Parkinson ’ s Disease Research, Education, and Clinical Center (PADRECC), VA Greater Los Angeles Healthcare ...’ s programming expertise in the CHAPS care management tool ... See full document
13
a-Synuclein Causes Non-Specific Toxicity in vps34 Yeast
... in model systems. The toxicity associated with GFP in vps34 yeast led to the analysis of another reporter gene; ...vps34 yeast, toxicity due to expression of LacZ is less than the ... See full document
9
α-synuclein in the pathophysiology of Alzheimer’s disease
... Numerous clinical studies have by now documented the presence of αSyn pathology in patients with AD, how- ever, little attention has been devoted to αSyn as a po- tential target for AD disease-modification, ... See full document
19
<p>Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson’s Disease</p>
... MPTP model of PD remains unknown. In the current study, the p- α -Synuclein and p-Tau protein level, and GSK3 β activation in PD mouse model were ...mouse model of PD and proposed the possible ... See full document
13
INSILICO DOCKING STUDIES TO IDENTIFY POTENT INHIBITORS OF ALPHA SYNUCLEIN AGGREGATION IN PARKINSON DISEASE
... elsewhere. Using the FlexX algorithm, up to 200 poses are generated for each compound and the best pose wise and the compound with the best docking score was selected as a potent inhibitor for ... See full document
5
Related subjects